Pfizer Investigator Sponsored Research — Rare Disease Areas of Interest

About this program

Pfizer’s Investigator‑Sponsored Research program invites qualified researchers to submit unsolicited proposals for investigator‑initiated studies in selected rare‑disease areas—including long‑acting growth hormone in endocrinology, hemophilia and other bleeding disorders, sickle cell disease, and TTR amyloidosis related to tafamidis—and may provide funding and/or drug supply. Applicants must follow Pfizer’s application windows and batched review cycles and submit proposals according to the guidance at www.pfizer.com/ISR; submissions are reviewed by Pfizer Global Reviewers and are not guaranteed approval. Formal notification will be sent after review, and any Pfizer support is contingent upon execution of a research agreement; inquiries may be directed to GlobalMedicalGrants@pfizer.com.